Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01788683 · ClinicalTrials.gov registry record · NA
Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears
A NA study of Rotator Cuff Tear, sponsored by Regenexx.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT01788683: Completed NA study of Rotator Cuff Tear, sponsored by Regenexx.
NCT01788683 is a NA study of Rotator Cuff Tear that has completed, run by Regenexx. The registered enrollment target is 51 participants, below the 89-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01788683, a NA study of Rotator Cuff Tear, has completed, sponsored by Regenexx.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to compare the improvement in subject-reported clinical outcomes, for Regenexx SD treatment vs. Exercise Therapy of non-retracted supraspinatus tendon tears, from baseline to 3 months, with continued evaluation of efficacy and durability up to 24 months. Secondary objectives include evaluation of US evidence of tendon repair; incidence of post-operative complications, adverse events, re-injections, and surgical intervention; change in pain score and use of pain medications.
Primary Outcome
The primary endpoint for this study is the difference between treatment groups in the within patient mean change from baseline to 3 months in Disabilities of the Arm Shoulder and Hand (DASH) scores.
Conditions Studied
Interventions
- PROCEDURE Regenexx SD
- OTHER Exercise Therapy
Study Locations (1)
Colorado
- Centeno-Schultz Clinic - Broomfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-02 |
| Est. Completion | 2022-07-28 |
| Phase | NA |
What the finished NCT01788683 record still lists
NCT01788683 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 89-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Rotator Cuff Tear appearing as the primary indexed condition, and to 2 interventions - of which Regenexx SD is the first listed.
NCT01788683 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01788683 about?
NCT01788683 is a clinical study titled "Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears". The primary objective of this study is to compare the improvement in subject-reported clinical outcomes, for Regenexx SD treatment vs. Exercise Therapy of non-retracted supraspinatus tendon tears, from baseline to 3 months, with continued evaluation of efficacy and durability up to 24 months. Secon...
What is the current status of trial NCT01788683?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-02. Estimated completion is 2022-07-28.
What conditions does trial NCT01788683 study?
This clinical trial studies the following conditions: Rotator Cuff Tear.
What interventions are being tested in trial NCT01788683?
The interventions under investigation include: Regenexx SD (PROCEDURE), Exercise Therapy (OTHER).
Who is sponsoring clinical trial NCT01788683?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01788683 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01788683's enrollment target sits among peer trials
51 12th of 11 the lowest of 11 other Rotator Cuff Tear trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tear trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
Oxandrolone Rotator Cuff Trial
ACTIVE NOT RECRUITING · NA
-
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
ACTIVE NOT RECRUITING · NA
-
Vascular Changes of Rotator Cuff Repair Augmented With a Whole Blood Fibrin Clot
COMPLETED · NA
-
BioWick SureLock Clinical Outcomes Study
COMPLETED · NA
-
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia